Skip to main content

Table 1 Demographic and clinical characteristics of the study cohort by AMD classification

From: Mental health and visual acuity in patients with age-related macular degeneration

 

Early/Int. AMD

Advanced AMD

eiAMD

GA

NV AMD

Both Advanceda

Number of Patients

370

135

198

172

Female gender

61.4%

57.0%

58.6%

61.6%

Age, Mean (SD)**

75.2 (11.4)

81.1 (9.8)

78.0 (10.1)

81.7 (7.9)

Race/ethnicity

 White

352 (95.1%)

128 (94.8%)

186 (93.9%)

163 (94.8%)

 Hispanic

6 (1.6%)

5 (3.7%)

5 (2.5%)

3 (1.7%)

 African American

4 (1.1%)

1 (0.7%)

3 (1.5%)

3 (1.7%)

 Asian

3 (0.8%)

1 (0.7%)

1 (0.5%)

3 (1.7%)

 Other

5 (1.4%)

0 (0%)

3 (1.5%)

0 (0%)

Marriedǂ

127 (34.6%)

49 (36.3%)

74 (38.1%)

78 (45.9%)

Bilateral advanced stage**

-

71.8%

18.2%

80.8%

Lens status**

 Pseudophakic, both

205 (55.4%)

96 (71.1%)

109 (55.0%)

114 (66.3%)

 Pseudophakic, one

19 (5.1%)

9 (6.7%)

18 (9.1%)

19 (11.0%)

 Cataract, both

142 (38.4%)

30 (22.2%)

70 (35.4%)

38 (22.1%)

 Phakic, both

4 (1.1%)

0 (0%)

1 (0.5%)

1 (0.6%)

HVA in better-seeing eye**

 Mean (SD) LogMAR

0.096 (0.12)

0.379 (0.31)

0.165 (0.20)

0.430 (0.46)

 Median LogMAR

0.097

0.301

0.097

0.301

 Median Snellen

20/25

20/40

20/25

20/40

HVA in worse-seeing eye**

 Mean (SD) LogMAR

0.265 (0.34)

0.800 (0.73)

0.699 (0.81)

1.253 (1.01)

 Median LogMAR

0.176

0.602

0.398

0.835

 Median Snellen

20/30

20/80

20/50

20/140

  1. HVA is habitual visual acuity
  2. a The number of patients with the various combinations included in the Both Advanced groups are described in detail in Table 2
  3. ** Significantly different across groups, p < 0.05
  4. ǂ p < 0.10 across groups